Beautiful Virgin Islands

Tuesday, Jul 22, 2025

Italy blocks 250,000 doses of AstraZeneca Covid-19 vaccine from reaching Australia in first for EU – reports

Italy blocks 250,000 doses of AstraZeneca Covid-19 vaccine from reaching Australia in first for EU – reports

The Italian government has reportedly prevented a shipment of some 250,000 doses of the Covid-19 vaccine developed by AstraZeneca and Oxford University from leaving the country for Australia, in the first such action in the EU.
Rome's ban on exporting AstraZeneca jabs made at Italy’s Anagni plant for Canberra was first reported by the Financial Times, citing Italian government sources.

It is the first such move by an EU member state since Brussels brought in new rules allowing governments to halt shipments to other countries of vaccines produced in the bloc in order to protect European interests.

The Italian government told the European Commission of its intention last week and Brussels did not object to the move, according to the FT.

Last week, Italy's new Prime Minister Mario Draghi told a meeting of EU leaders that the bloc's vaccine rollout must speed up. He also reportedly called for tougher action on vaccine manufacturers that don't meet their commitments, and for the EU to restrict sending jabs elsewhere in a bid to strengthen its own rollout.

At the end of January, the Commission announced a new measure requiring member states to authorize vaccine exports to non-EU nations in a bid to create greater "transparency" and to protect vaccine supplies.

The scheme covers EU vaccine contracts the EU has signed advance purchase agreements for. It was due to expire at the end of March, but is to be extended until the end of June, Reuters reported on Thursday.

The measure was introduced following a huge public row between the EU and the UK over AstraZeneca vaccine supplies that officially left the bloc at the beginning of 2021. In January, the British-Swedish pharmaceutical company announced it would cut EU deliveries from a target figure of 80 million to 31 million due to production shortfalls at its plants in Belgium and the Netherlands.

Brussels accused the drugmaker of reneging on its vaccine contract and even threatened to invoke Brexit legislation to stop jabs entering the UK via Northern Ireland. It eventually backed down after backlash from London, Dublin and Belfast.

Italy's reported blockage on shipping the vaccine doses to Australia has not yet been confirmed publicly by officials.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
×